Healthcare provider profile · identity verified

Lori Marie Hill, ARNP

Nurse Practitioner · ST PETERSBURG, FL · NPI 1477794741

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	680	256
Losartan Potassium	Losartan Potassium	351	129
Levothyroxine Sodium	Levothyroxine Sodium	347	128
Amlodipine Besylate	Amlodipine Besylate	324	123
Metformin Hcl	Metformin Hcl	275	95
Lisinopril	Lisinopril	257	94
Rosuvastatin Calcium	Rosuvastatin Calcium	245	103
Pantoprazole Sodium	Pantoprazole Sodium	234	86
Tamsulosin Hcl	Tamsulosin Hcl	209	72
Metoprolol Tartrate	Metoprolol Tartrate	208	73
Trazodone Hcl	Trazodone Hcl	192	73
Simvastatin	Simvastatin	189	58
Escitalopram Oxalate	Escitalopram Oxalate	163	61
Fluticasone Propionate	Fluticasone Propionate	160	61
Prednisone	Prednisone	145	82
Albuterol Sulfate Hfa	Albuterol Sulfate	143	66
Meloxicam	Meloxicam	137	55
Hydrochlorothiazide	Hydrochlorothiazide	136	51
Omeprazole	Omeprazole	122	54
Methylprednisolone	Methylprednisolone	115	105
Furosemide	Furosemide	114	44
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	107	58
Famotidine	Famotidine	107	42
Pravastatin Sodium	Pravastatin Sodium	107	39
Alprazolam	Alprazolam	102	34
Clopidogrel	Clopidogrel Bisulfate	101	37
Gabapentin	Gabapentin	101	44
Carvedilol	Carvedilol	96	37
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	88	83
Warfarin Sodium	Warfarin Sodium	87	27
Metoprolol Succinate	Metoprolol Succinate	81	33
Montelukast Sodium	Montelukast Sodium	80	34
Glipizide	Glipizide	78	36
Allopurinol	Allopurinol	75	24
Azithromycin	Azithromycin	67	65
Citalopram Hbr	Citalopram Hydrobromide	67	22
Alendronate Sodium	Alendronate Sodium	66	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	22
Pioglitazone Hcl	Pioglitazone Hcl	60	15
Bupropion Xl	Bupropion Hcl	56	22
Buspirone Hcl	Buspirone Hcl	54	23
Meclizine Hcl	Meclizine Hcl	54	29
Finasteride	Finasteride	51	21
Baclofen	Baclofen	48	21
Donepezil Hcl	Donepezil Hcl	47	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	14
Metformin Hcl Er	Metformin Hcl	46	18
Duloxetine Hcl	Duloxetine Hcl	45	19
Mirtazapine	Mirtazapine	44	17
Zolpidem Tartrate	Zolpidem Tartrate	43	17
Nystatin	Nystatin	42	24
Potassium Chloride	Potassium Chloride	42	19
Spironolactone	Spironolactone	42	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	35
Lovastatin	Lovastatin	37	16
Sildenafil Citrate	Sildenafil Citrate	37	suppressed
Terbinafine Hcl	Terbinafine Hcl	36	14
Lorazepam	Lorazepam	34	13
Ibuprofen	Ibuprofen	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Fluconazole	Fluconazole	32	28
Mupirocin	Mupirocin	31	21
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	31	14
Ezetimibe	Ezetimibe	30	suppressed
Jantoven	Warfarin Sodium	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	25
Sertraline Hcl	Sertraline Hcl	28	13
Temazepam	Temazepam	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	17
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	11
Levofloxacin	Levofloxacin	24	22
Nifedipine Er	Nifedipine	24	11
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Atenolol	Atenolol	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	16
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Ondansetron Odt	Ondansetron	19	15
Clonidine Hcl	Clonidine Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Cephalexin	Cephalexin	17	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	17
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	11
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Topiramate	Topiramate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Clonazepam	Clonazepam	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Primidone	Primidone	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error